Kesch, C., Meyer, V., Praus, C., Costa, P. F., Ingenwerth, M., Darr, C., Radtke, J. P., Theysohn, J. M., Schaarschmidt, B., Reis, H., Fendler, W. P., Grünwald, V., Hadaschik, B. A., Herrmann, K. (2025). A phase I/II study of neoadjuvant, intra-arterial administration of (177Lu)lutetium vipivotide tetraxetan in subjects with high-risk, localised or locally advanced prostate cancer (LUPUS).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps431